Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852, USA.
J Biol Chem. 2013 Jul 26;288(30):22033-41. doi: 10.1074/jbc.M113.468108. Epub 2013 Jun 10.
Low density lipoprotein receptor (LDLR) was shown to mediate clearance of blood coagulation factor VIII (FVIII) from the circulation. To elucidate the mechanism of interaction of LDLR and FVIII, our objective was to identify the region of the receptor necessary for binding FVIII. Using surface plasmon resonance, we found that LDLR exodomain and its cluster of complement-type repeats (CRs) bind FVIII in the same mode. This indicated that the LDLR site for FVIII is located within the LDLR cluster. Similar results were obtained for another ligand of LDLR, α-2-macroglobulin receptor-associated protein (RAP), a common ligand of receptors from the LDLR family. We further generated a set of recombinant fragments of the LDLR cluster and assessed their structural integrity by binding to RAP and by circular dichroism. A number of fragments overlapping CR.2-5 of the cluster were positive for binding RAP and FVIII. The specificity of these interactions was tested by site-directed mutagenesis of conserved tryptophans within the LDLR fragments. For FVIII, the specificity was also tested using a single-chain variable antibody fragment directed against the FVIII light chain as a competitor. Both cases resulted in decreased binding, thus confirming its specificity. The mutagenic study also showed an importance of the conserved tryptophans in LDLR for both ligands, and the competitive binding results showed an involvement of the light chain of FVIII in its interaction with LDLR. In conclusion, the region of CR.2-5 of LDLR was defined as the binding site for FVIII and RAP.
低密度脂蛋白受体(LDLR)被证明可以介导清除循环中的凝血因子 VIII(FVIII)。为了阐明 LDLR 和 FVIII 相互作用的机制,我们的目标是确定受体结合 FVIII 所必需的区域。通过表面等离子体共振,我们发现 LDLR 外显子及其补体型重复簇(CRs)以相同的模式结合 FVIII。这表明 LDLR 与 FVIII 的结合部位位于 LDLR 簇内。对于 LDLR 的另一种配体α-2-巨球蛋白受体相关蛋白(RAP),也得到了类似的结果,RAP 是 LDLR 家族受体的共同配体。我们进一步生成了一组 LDLR 簇的重组片段,并通过与 RAP 和圆二色性结合来评估其结构完整性。一些与簇的 CR.2-5 重叠的片段与 RAP 和 FVIII 结合呈阳性。通过 LDLR 片段中保守色氨酸的定点突变测试了这些相互作用的特异性。对于 FVIII,还使用针对 FVIII 轻链的单链可变抗体片段作为竞争物进行了特异性测试。这两种情况都导致结合减少,从而证实了其特异性。诱变研究还表明,LDLR 中的保守色氨酸对于两种配体都很重要,竞争结合结果表明 FVIII 的轻链参与了其与 LDLR 的相互作用。总之,CR.2-5 区域被定义为 LDLR 与 FVIII 和 RAP 的结合位点。